Perspectives on the design of clinical trials combining transarterial chemoembolization and molecular targeted therapy.
about
Recent advances in multidisciplinary management of hepatocellular carcinomaManagement of Hepatocellular Carcinoma: Current Status and Future Directions.Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives.Clinical trials in hepatocellular carcinoma: an update.Early sorafenib-related adverse events predict therapy response of TACE plus sorafenib: A multicenter clinical study of 606 HCC patients.TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter, phase II SOCRATES trial.Combination of transcatheter arterial chemoembolization and interrupted dosing sorafenib improves patient survival in early-intermediate stage hepatocellular carcinoma: A post hoc analysis of the START trial.
P2860
Q26863748-CF6307BE-5870-4198-A229-3124D1C71818Q35771842-254024A7-6ADD-4C62-8F4D-B30AD4408C37Q37031712-B665B8D6-8421-4AB3-A307-E93813EBCEC6Q37435638-78B8EA55-E45E-4549-A96A-D52DCA98D2A3Q38886929-D5744CCC-DD9F-4EA3-80C3-D03DD888DFFCQ42199684-C9F6B390-A066-429D-827C-A6E0AFB57056Q42360747-35BAECD0-F5B5-40DE-8E51-7973B51050F2
P2860
Perspectives on the design of clinical trials combining transarterial chemoembolization and molecular targeted therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Perspectives on the design of ...... nd molecular targeted therapy.
@en
Perspectives on the design of ...... nd molecular targeted therapy.
@nl
type
label
Perspectives on the design of ...... nd molecular targeted therapy.
@en
Perspectives on the design of ...... nd molecular targeted therapy.
@nl
prefLabel
Perspectives on the design of ...... nd molecular targeted therapy.
@en
Perspectives on the design of ...... nd molecular targeted therapy.
@nl
P2093
P2860
P356
P1433
P1476
Perspectives on the design of ...... nd molecular targeted therapy.
@en
P2093
Ann-Lii Cheng
Fu-Chang Hu
Po-Ching-Liang
Satoshi Morita
P2860
P304
P356
10.1159/000343830
P577
2012-11-01T00:00:00Z